The Flowfect® Cell Engineering Grant
Accelerate the development of your cell therapy through a collaborative, science-driven process.
The Flowfect Tx® Cell Engineering Grant provides selected organizations with the opportunity to evaluate Flowfect® technology in collaboration with Kytopen's scientific and engineering teams. Designed to support researchers developing advanced ex vivo cell therapies, the program combines access to Flowfect® technology with scientific collaboration and workflow optimization to generate high-quality engineered cells.
Two winners will be selected to receive the following:
• Flowfect 96-well Discover™ Cell Engineering Optimization Service
• Installation of Flowfect Tx® platform for one week, including shipping
• Starter Kit (cartridges and buffer)
• On-site instruction and training by Kytopen Field Application Scientist
★ Submission Deadline: October 15th | WInner Announced: October 31st ★
WHY YOU SHOULD APPLY
Accelerating the Future of Medicine
At Kytopen, our scalable genome-engineering platform solves cell therapy manufacturing challenges, expanding patient access to the next generation of advanced cell therapies.
Our non-viral continuous flow technology empowers researchers and developers to